[Growth and body composition in children with type 1 diabetes mellitus]

Maria F V M Paulino1, Sofia H V de Lemos-Marini, Gil Guerra-Júnior

  • 1Hospital de Clínicas, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (UNICAMP), Rua Antonio Augusto de Almeida 182, 13084-755 Campinas, SP. rspaulino@hotmail.com

Insights

Pre-pubertal children with diabetes showed reduced height standard deviation scores (SDS) and increased arm fat compared to controls. Diabetes duration influenced height SDS reduction in these young patients.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Growth and Development

Background:

  • Type 1 diabetes is a chronic condition affecting children.
  • Understanding the impact of diabetes on growth and body composition is crucial for management.
  • Pre-pubertal children with diabetes may experience altered growth patterns.

Purpose of the Study:

  • To assess growth and body composition in pre-pubertal diabetic children.
  • To investigate the influence of diabetes duration, age of onset, sex, insulin needs, and glycemic control (HbA1c) on these parameters.

Main Methods:

  • A cohort of 59 pre-pubertal diabetic children and 67 healthy controls were studied.
  • Measurements included weight, height, BMI, arm circumference, skinfolds, fat mass, and muscle area, all converted to standard deviation scores (SDS).

Main Results:

  • Diabetic children had significantly lower mean height SDS (-0.13) compared to controls (0.28).
  • Height SDS significantly decreased over time, correlated with diabetes duration.
  • Arm fat SDS was significantly higher in diabetic children compared to controls.

Conclusions:

  • Pre-pubertal diabetic children exhibit reduced height SDS and increased arm fat compared to controls.
  • The duration of diabetes is a significant factor in the observed decrease in height SDS.
  • Despite differences, the children's statures remained within population standards.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...